DiPietro Kenneth 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Dec 27, 2023
Insider Transaction Report
Form 4
DiPietro Kenneth
Chief Human Resources Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-12-22−8,000→ 302,242 totalExercise: $3.50Exp: 2029-04-02→ Common Stock (8,000 underlying) - Exercise/Conversion
Common Stock
2023-12-22$3.50/sh+8,000$28,000→ 32,663 total - Sale
Common Stock
2023-12-22$41.45/sh−8,000$331,608→ 24,663 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $41.45 to $41.46. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option is fully vested and exercisable.